J. D. den Boer

J. D. den Boer, R. Minderaa, N. V. van Lang, 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Somatosensory Profiles but Not Numbers of Somatosensory Abnormalities of Neuropathic Pain Patients Correspond with Neuropathic Pain Grading

M. Struys, J. D. den Boer, R. Kortekaas, 2012, PloS one.

Neutrophil gelatinase-associated lipocalin: a novel inflammatory marker associated with late-life depression.

N. Groenewold, J. D. den Boer, R. O. Oude Voshaar, 2013, Journal of psychosomatic research.

Irritability Rather Than Depression During Interferon Treatment Is Linked to Increased Tryptophan Catabolism

J. Korf, E. D. de Vries, J. D. den Boer, 2005, Psychosomatic medicine.

The reliability and validity of the Seasonal Pattern Assessment Questionnaire: a comparison between patient groups.

A. Bouhuys, R. H. van den Hoofdakker, P. Mersch, 2004, Journal of affective disorders.

The prediction of nonresponse to pharmacotherapy in panic disorder: A review

J. D. den Boer, B. Slaap, 2001, Depression and anxiety.

Responders and non-responders to drug treatment in social phobia: differences at baseline and prediction of response.

H. Westenberg, J. D. den Boer, I. V. van Vliet, 1996, Journal of affective disorders.

Molecular correlates of impaired prefrontal plasticity in response to chronic stress

J. D. den Boer, A. Trentani, S. Kuipers, 2003, Journal of Neurochemistry.

Acute and chronic effects of citalopram on postsynaptic 5‐hydroxytryptamine1A receptor‐mediated feedback: a microdialysis study in the amygdala

H. Wikström, B. Westerink, J. D. den Boer, 2001, Journal of neurochemistry.

Case History 1

J. D. den Boer, F. Rouillon, 1997 .

Platelet serotonin levels in pervasive developmental disorders and mental retardation: diagnostic group differences, within-group distribution, and behavioral correlates.

J. D. den Boer, R. Minderaa, G. Anderson, 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

The effect of mirtazapine in panic disorder: an open label pilot study with a single-blind placebo run-in period

J. D. den Boer, M. Boshuisen, E. Vester-Blokland, 2001, International clinical psychopharmacology.

Chronic stress and antidepressant agomelatine induce region‐specific changes in synapsin I expression in the rat brain

J. D. den Boer, C. Gabriel, P. Luiten, 2011, Journal of neuroscience research.

The Novel Antidepressant Agomelatine Normalizes Hippocampal Neuronal Activity and Promotes Neurogenesis in Chronically Stressed Rats

J. D. den Boer, P. Meerlo, C. Gabriel, 2010, European Psychiatry.

Chronically restricted sleep leads to depression-like changes in neurotransmitter receptor sensitivity and neuroendocrine stress reactivity in rats.

J. D. den Boer, P. Meerlo, P. Luiten, 2008, Sleep.

The Psychobiology of Authentic and Simulated Dissociative Personality States: The Full Monty

A. Reinders, A. Willemsen, J. D. den Boer, 2016, The Journal of nervous and mental disease.

Serotonergic drugs in the treatment of depressive and anxiety disorders

J. D. den Boer, F. Bosker, B. Slaap, 2000, Human psychopharmacology.

Chronic stress and antidepressant treatment have opposite effects on P-glycoprotein at the blood—brain barrier: an experimental PET study in rats

A. van Waarde, A. Willemsen, J. D. den Boer, 2010, Journal of psychopharmacology.

Lung function and bronchial responsiveness measured by forced oscillometry after bronchopulmonary dysplasia.

J. D. den Boer, E. Duiverman, K. Kerrebijn, 1988, Archives of disease in childhood.

Patients with obsessive–compulsive disorder are impaired in associative learning based on external feedback

J. A. Boer, J. D. den Boer, H. Smid, 2009, Psychological Medicine.

Neuropsychological performance of OCD patients before and after treatment with fluoxetine: evidence for persistent cognitive deficits

J. D. den Boer, M. Nielen, J. DEN BOER, 2003, Psychological Medicine.

An Animal Model of Emotional Blunting in Schizophrenia

T. Vladusich, J. D. den Boer, J. Doorduin, 2007, PloS one.

Fact or Factitious? A Psychobiological Study of Authentic and Simulated Dissociative Identity States

A. Willemsen, J. D. den Boer, E. Nijenhuis, 2012, PloS one.

Clinical efficacy of agomelatine in depression: the evidence

J. A. Boer, J. D. den Boer, F. Bosker, 2005 .

Impaired Attribution of Emotion to Facial Expressions in Anxiety and Major Depression

A. Aleman, L. Demenescu, J. D. den Boer, 2010, PloS one.

Social phobia: epidemiology, recognition, and treatment

J. D. den Boer, 1997, BMJ.

5‐HT1A receptor imaging in the human brain: Effect of tryptophan depletion and infusion on [18F]MPPF binding

Jan Pruim, J. Pruim, A. van Waarde, 2002 .

Reduced spontaneous but relatively normal deliberate vicarious representations in psychopathy

Christian Keysers, Valeria Gazzola, Harma Meffert, 2013, Brain : a journal of neurology.

Fear conditioning and shock intensity: the choice between minimizing the stress induced and reducing the number of animals used

J. D. den Boer, F. Bosker, C. Pietersen, 2004, Laboratory animals.

The Psychobiology of Burnout: Are There Two Different Syndromes?

Maarten A. S. Boksem, A. A. Wijers, T. Meijman, 2007, Neuropsychobiology.

A Forced Desynchrony Study of Circadian Pacemaker Characteristics in Seasonal Affective Disorder

R. H. van den Hoofdakker, J. D. den Boer, D. Beersma, 2002, Journal of biological rhythms.

A double-blind comparative study of brofaromine and fluvoxamine in outpatients with panic disorder.

H. Westenberg, J. D. den Boer, I. V. van Vliet, 1996, Journal of clinical psychopharmacology.

UvA-DARE ( Digital Academic Repository ) Symptom Dimensions in OCD : Item-Level Factor Analysis and Heritability Estimates

Dan J Stein, M. Jenike, J. Grant, 2010 .

The role of the COMT Val158Met polymorphism in the phenotypic expression of obsessive‐compulsive disorder

A. V. van Balkom, D. Denys, P. Heutink, 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Clinical effects of buspirone in social phobia: a double-blind placebo-controlled study.

H. Westenberg, J. D. den Boer, I. V. van Vliet, 1997, The Journal of clinical psychiatry.

Five-minute recordings of heart rate variability in obsessive-compulsive disorder, panic disorder and healthy volunteers.

A. V. van Roon, J. D. den Boer, M. Boshuisen, 2004, Journal of affective disorders.

Heart rate variability as predictor of nonresponse to mirtazapine in panic disorder: a preliminary study

A. V. van Roon, J. D. den Boer, M. Boshuisen, 2002, International clinical psychopharmacology.

Pituitary-Adrenal and Sympathetic Nervous System Responses to Stress in Women Remitted From Recurrent Major Depression

J. D. den Boer, B. Krumm, M. Deuschle, 2008, Psychosomatic medicine.

Risperidone in the treatment of psychosis; a concise review

J. D. den Boer, 1995, Acta Neuropsychiatrica.

Latent class analysis of the Yale-Brown Obsessive-Compulsive Scale symptoms in obsessive-compulsive disorder.

S. E. Stewart, D. Stein, M. Jenike, 2011, Comprehensive psychiatry.

Risk of emotional disorder in offspring of depressed parents: gender differences in the effect of a second emotionally affected parent

J. Ormel, C. Hartman, J. D. den Boer, 2008, Depression and anxiety.

Sleep in seasonal affective disorder patients in forced desynchrony: an explorative study

R. H. van den Hoofdakker, J. D. den Boer, D. Beersma, 2002, Journal of sleep research.

Serotonergic compounds in panic disorder, obsessive‐compulsive disorder and anxious depression: A concise review

H. Westenberg, J. D. den Boer, H. G. M. Westenberg, 1995, Human psychopharmacology.

Processes of change in cognitive-behavioural treatment of obsessive-compulsive disorder: Current status and some future directions.

J. D. den Boer, T. Bouman, P. D. de Jong, 2009, Clinical psychology & psychotherapy.

Differential effects of olanzapine and risperidone on cognition in schizophrenia? A saccadic eye movement study.

T. Crawford, J. D. den Boer, A. Broerse, 2002, The Journal of neuropsychiatry and clinical neurosciences.

Is a combined therapy more effective than either CBT or SSRI alone? Results of a multicenter trial on panic disorder with or without agoraphobia

W. Hale, P. Mersch, M. Huisman, 2008, Acta psychiatrica Scandinavica.

A randomized trial of cognitive-behavioral therapy or selective serotonin reuptake inhibitor or both combined for panic disorder with or without agoraphobia: treatment results through 1-year follow-up.

P. Mersch, M. Timmerman, J. D. den Boer, 2010, The Journal of clinical psychiatry.

Decision making performance in obsessive compulsive disorder.

G. Mulder, D. Veltman, J. D. den Boer, 2002, Journal of affective disorders.

Considering depression as a consequence of activation of the inflammatory response system

J. Korf, J. D. den Boer, J. Versijpt, 2002, Acta Neuropsychiatrica.

Serotonin-influencing drugs in the treatment of panic disorder.

H. Westenberg, J. D. den Boer, 1989, Psychopathology.

Patients With Carcinoid Syndrome Exhibit Symptoms of Aggressive Impulse Dysregulation

J. Korf, E. D. de Vries, J. D. den Boer, 2004, Psychosomatic medicine.

Biological dissection of anxiety disorders: the clinical role of selective serotonin reuptake inhibitors with particular reference to fluvoxamine

H. Westenberg, J. D. den Boer, I. V. van Vliet, 1995, International clinical psychopharmacology.

Rate of improvement during and across three treatments for panic disorder with or without agoraphobia: cognitive behavioral therapy, selective serotonin reuptake inhibitor or both combined.

P. Mersch, M. Timmerman, J. D. den Boer, 2013, Journal of affective disorders.

The Yale-Brown Obsessive-Compulsive Scale: Factor Structure of a Large Sample

Johannes H. Smit, Danielle C. Cath, J. Smit, 2010, Front. Psychiatry.

Phobic symptoms as predictors of nonresponse to drug therapy in panic disorder patients (a preliminary report).

H. Westenberg, J. D. den Boer, I. V. van Vliet, 1995, Journal of affective disorders.

Remoxipride, a novel atypical neuroleptic, in the treatment of schizophrenia.

W. Verhoeven, H. Westenberg, J. D. den Boer, 1987, Psychopharmacology bulletin.

Chronic stress and antidepressant agomelatine induce region‐specific changes in synapsin I expression in the rat brain

J. D. den Boer, C. Gabriel, P. Luiten, 2011, Journal of neuroscience research.

Regional increase in P-glycoprotein function in the blood-brain barrier of patients with chronic schizophrenia: A PET study with [11C]verapamil as a probe for P-glycoprotein function

J. A. Boer, A. Willemsen, J. D. den Boer, 2010, Psychiatry Research: Neuroimaging.

The robustness of perception

C. Büchel, J. A. den Boer, A. Reinders, 2005, The European journal of neuroscience.

The Novel Antidepressant Agomelatine Normalizes Hippocampal Neuronal Activity and Promotes Neurogenesis in Chronically Stressed Rats

J. D. den Boer, P. Meerlo, C. Gabriel, 2010, CNS neuroscience & therapeutics.

Circulating Cerebral S100B Protein Is Associated with Depressive Symptoms following Myocardial Infarction

J. Korf, P. de Jonge, J. D. den Boer, 2009, Neuropsychobiology.

Sleep in seasonal affective disorder patients in forced desynchrony: an explorative study

R. H. van den Hoofdakker, J. D. den Boer, D. Beersma, 2002, Journal of sleep research.

Effect of a serotonin and noradrenaline uptake inhibitor in panic disorder; a double-blind comparative study with fluvoxamine and maprotiline.

H. Westenberg, J. D. den Boer, 1988, International clinical psychopharmacology.